<?xml version='1.0' encoding='utf-8'?>
<?xml-stylesheet type="text/xsl" href="/v2/static/oai2.xsl"?>
<OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2026-10-07T18:33:16Z</responseDate>
  <request identifier="oai:figshare.com:article/32641329" metadataPrefix="oai_dc" verb="GetRecord">https://api.figshare.com/v2/oai</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:figshare.com:article/32641329</identifier>
        <datestamp>2026-10-01T16:24:04Z</datestamp>
        <setSpec>portal_1172</setSpec>
        <setSpec>item_type_8</setSpec>
        <setSpec>month_year_10_2026</setSpec>
      </header>
      <metadata>
        <oai_dc:dc xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"  xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
          <dc:title>Development and evaluation of microneedles for ocular drug delivery</dc:title>
          <dc:creator>Katie Glover (24169932)</dc:creator>
          <dc:subject>PUREID: 642260186</dc:subject>
          <dc:subject>microneedles</dc:subject>
          <dc:subject>ocular drug delivery</dc:subject>
          <dc:subject>biomechanics</dc:subject>
          <dc:subject>sclera</dc:subject>
          <dc:description>This PhD research tackles the challenge of drug delivery to the posterior eye, where current methods often cause discomfort, side effects, and limited efficacy. The study explores a novel, minimally invasive approach using a single hollow microneedle for targeted and sustained ocular delivery. Scleral biomechanics were characterised using uniaxial testing and advanced imaging to guide microneedle optimisation. Safe  insertion forces and accurate penetration depths were achieved using ex vivo porcine sclera, supported by a whole-eye model that monitored intraocular pressure in real time. A 3D cohesive zone finite element model simulated insertion mechanics. To enhance drug retention, formulation strategies were explored, showing that higher  viscosity and particle size improved scleral retention. A nanosuspension of axitinib was developed for intrascleral retention, with safety confirmed via cytotoxicity testing and HET-CAM assay. This work establishes a promising intrascleral delivery platform and provides a strong foundation for future clinical translation.&lt;br&gt;&lt;br&gt;&lt;i&gt;Thesis embargoed until 31st July 2030.&lt;/i&gt;</dc:description>
          <dc:date>2026-10-01T16:24:04Z</dc:date>
          <dc:type>Text</dc:type>
          <dc:type>Thesis</dc:type>
          <dc:identifier>10.17034/32641329.v1</dc:identifier>
          <dc:relation>https://figshare.com/articles/thesis/Development_and_evaluation_of_microneedles_for_ocular_drug_delivery/32641329</dc:relation>
          <dc:rights>All Rights Reserved</dc:rights>
          <dc:rights>Open Access after 2030-07-31</dc:rights>
        </oai_dc:dc>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
